Saba Capital Management Amends Filing for BlackRock MuniYield PA Quality Fund
Ticker: MPA · Form: SC 13D/A · Filed: May 21, 2024 · CIK: 891038
Sentiment: neutral
Topics: sec-filing, 13d-amendment, ownership-disclosure
TL;DR
Saba Capital updated its 13D filing for BlackRock MuniYield PA Quality Fund. #SECfilings
AI Summary
Saba Capital Management, L.P. has filed an amendment (Amendment No. 10) to its Schedule 13D/A concerning BlackRock MuniYield Pennsylvania Quality Fund. The filing, dated May 21, 2024, indicates a change in the reporting of beneficial ownership. Saba Capital Management, L.P. is a Delaware-based entity with its principal business address in New York, NY.
Why It Matters
This amendment signifies a change in the ownership or control disclosures for a municipal bond fund, which could impact investor sentiment and the fund's strategic direction.
Risk Assessment
Risk Level: medium — Amendments to Schedule 13D filings often indicate shifts in significant beneficial ownership, which can lead to changes in fund management or strategy, introducing potential volatility.
Key Players & Entities
- Saba Capital Management, L.P. (company) — Filer of the Schedule 13D/A
- BlackRock MuniYield Pennsylvania Quality Fund (company) — Subject company of the filing
- Boaz R. Weinstein (person) — Group member associated with Saba Capital Management
- Saba Capital Management GP, LLC (company) — Group member associated with Saba Capital Management
FAQ
What is the purpose of this SC 13D/A filing?
This filing is an amendment (Amendment No. 10) to a Schedule 13D, which is used to report beneficial ownership of securities.
Who is the subject company of this filing?
The subject company is BlackRock MuniYield Pennsylvania Quality Fund.
Who is the entity filing this amendment?
The filing is made by Saba Capital Management, L.P.
What is the filing date of this amendment?
The filing date is May 21, 2024.
What is the Central Index Key (CIK) for BlackRock MuniYield Pennsylvania Quality Fund?
The CIK for BlackRock MuniYield Pennsylvania Quality Fund is 0000891038.
Filing Stats: 1,378 words · 6 min read · ~5 pages · Grade level 12.8 · Accepted 2024-05-21 16:10:13
Key Financial Figures
- $0.10 — FUND (Name of Issuer) Common Shares, $0.10 par value (Title of Class of Securiti
- $25,023,498 — ported herein. A total of approximately $25,023,498 was paid to acquire the Common Shares r
Filing Documents
- formsc13da.htm (SC 13D/A) — 55KB
- 0001062993-24-010861.txt ( ) — 57KB
is hereby amended and supplemented as follows
Item 4 is hereby amended and supplemented as follows: The Reporting Persons issued the investor presentation (the "Investor Presentation") attached hereto as Exhibit 3 to shareholders (such exhibit to be deemed incorporated by reference in its entirety into this Item 4) providing their views on the Issuer and its Board, including value-unlocking steps it believes the Issuer should take. Item 5. INTEREST IN SECURITIES OF THE ISSUER (a) See rows (11) and (13) of the cover pages to this Schedule 13D/A for the aggregate number of Common Shares and percentages of the Common Shares beneficially owned by each of the Reporting Persons. The percentages used herein are calculated based upon 12,949,630 shares of common stock outstanding as of 1/31/24, as disclosed in the company's N-CSRS filed 4/3/24 (b) See rows (7) through (10) of the cover pages to this Schedule 13D/A for the number of Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition. (c) The transactions in the Common Shares effected since the Schedule 13D/A filing on 4/15/24 by the Reporting Persons, which were all in the open market, are set forth in Schedule A, and are incorporated herein by reference (d) The funds and accounts advised by Saba Capital have the right to receive the dividends from and proceeds of sales from the Common Shares. (e) Not applicable. Item 7. MATERIAL TO BE FILED AS EXHIBITS Exhibit 3: Investor Presentation, incorporated herein by reference to the DFAN14A filed with the Securities and Exchange Commission on May 20, 2024.
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: May 21, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital since the filing of the Schedule 13D/A on 4/15/24. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 4/15/2024 Buy 29,645 11.96 4/16/2024 Buy 32,876 12.03 4/17/2024 Buy 5,333 12.14